Skip to main content
Log in

Increased frequency of blaNDM in a tertiary care hospital in southern Brazil

  • Clinical Microbiology – Short Communication
  • Published:
Brazilian Journal of Microbiology Aims and scope Submit manuscript

Abstract

Resistance to carbapenems due to metallo-beta-lactamase NDM-1 was first described in Brazil in 2013. To date, only a few scattered reports of the prevalence of NDM-1 in the country have been reported, and most of them indicated a very low prevalence of this metalloenzyme. In the present study, we report a steady increase in the frequency of NDM among Enterobacterales resistant to carbapenems in a tertiary care hospital in southern Brazil. Carbapenemase genes were evaluated by multiplex real-time polymerase chain using high-resolution melting analysis among 3501 isolates of 8 different species of Enterobacterales recovered from January 2015 to May 2020. The blaKPC-like was identified in 3003 isolates (85.8%) and the blaNDM-like was the second most common gene (351 isolates—10%). There was a steady increase in frequency of blaNDM-like, from 4.2% in 2015 to 24% in 2020. The increase of blaNDM frequency raises an important matter as novel therapeutic options are currently very limited for the treatment of patients infected by bacteria carrying the blaNDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Carvalho-Assef AP, Pereira PS, Albano RM, Berião GC, Chagas TP, Timm LN, Silva RCF, Falci DR, Asensi MD (2013) Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother 68:2956–2957. https://doi.org/10.1093/jac/dkt298

    Article  CAS  PubMed  Google Scholar 

  2. da Silva IR, Aires CAM, Conceição-Neto OC, Santos ICO, Pereira NF, Senna JPM, Carvalho-Assef AP, Asensi MD, Rocha-de-Souza CM (2019) Distribution of clinical NDM-1-producing gram-negative bacteria in Brazil. Microb Drug Resist 25:394–399. https://doi.org/10.1089/mdr.2018.0240

    Article  CAS  PubMed  Google Scholar 

  3. Rozales FP, Ribeiro VB, Magagnin CM, Pagano M, Lutz L, Falci DR, Machado A, Barth AL, Zavascki AP (2014) Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 25:79–81. https://doi.org/10.1016/j.ijid.2014.01.005

    Article  PubMed  Google Scholar 

  4. Sampaio JLM, Gales AC (2016) Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on b-lactams and polymyxins. 2016. Braz J Microbiol 47:31–37. https://doi.org/10.1016/j.bjm.2016.10.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Clinical and Laboratory Standards Institute (2014) Performance standards for antimicrobial susceptibility testing. Twenty-Fourth informational supplement. M100-S24. CLSI, Wayne

    Google Scholar 

  6. Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S (2012) Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67:906–909. https://doi.org/10.1093/jac/dkr563

    Article  CAS  PubMed  Google Scholar 

  7. Rozales FP, Lovison OA, Magagnin CM, Martins AS, Crispim MN, Zavascki AP, Barth AL (2017) Characteristics of Enterobacteriaceae isolates coharboring distinct carbapenemase genes. Infect Control Hosp Epidemiol 38:1123–1126. https://doi.org/10.1017/ice.2017.146

    Article  PubMed  Google Scholar 

  8. Balm MN, La MV, Krishnan P, Jureen R, Lin RT, Teo JW (2013) Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect 19:421–423. https://doi.org/10.1111/1469-0691

    Article  Google Scholar 

  9. Both A, Huang J, Kaase M, Hezel J, Wertheimer D, Fenner I, Günther T, Grundhoff A, Büttner H, Aepfelbacher M, Rohde H, Hentschke M (2016) First report of Escherichia coli co-producing NDM-1 and OXA-232. Diagn Microbiol Infect Dis 86:437–438. https://doi.org/10.1016/j.diagmicrobio.2016.09.005

    Article  CAS  PubMed  Google Scholar 

  10. Karlowsky JA, Kazmierczak KM, de Jonge BLM, Hackel MA, Sahm DF, Bradford PA (2017) In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015. Antimicrob Agents Chemother 61. https://doi.org/10.1128/AAC.00472-17

Download references

Funding

This work has been funded by INPRA - Instituto Nacional de Pesquisa em Resistência Antimicrobiana - Brazil (INCT/CNPq: 465718/2014-0 and INCT/FAPERGS: 17/2551-0000514-7) and by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre (FIPE/HCPA) (Project no. 19-0203).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Priscila Lamb Wink.

Ethics declarations

Conflict of interest

APZ received a research grant from Pfizer.

Additional information

Responsible Editor: Jorge Luiz Mello Sampaio

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wink, P.L., Martins, A.S., Volpato, F. et al. Increased frequency of blaNDM in a tertiary care hospital in southern Brazil. Braz J Microbiol 52, 299–301 (2021). https://doi.org/10.1007/s42770-020-00412-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42770-020-00412-z

Keywords

Navigation